Another intriguing avenue of investigation revolves around Gal-1’s potential as a predictor of extended survival in pancreatic carcinoma cases, with preliminary results indicating a sensitivity rate of 64% and a specificity rate of 90% [78]. The gene discussed is LGALS1; the disease is exocrine pancreatic carcinoma.